Evidence map›Paper›PMID 40330764›Full record

ReviewHealth science reports2025

The Effect of

Amirali Aali, Erfan Taherifard, Melika Farshidianfar, Farshad Hadianfard, Fatemeh Alamdari, Omid Keshavarzian, Majid Nimrouzi, Seyed Taghi Heydari, Maryam Akbari

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Amirali AaliHealth Policy Research Center, Institute of Health Shiraz University of Medical Sciences Shiraz Iran.
Erfan TaherifardHealth Policy Research Center, Institute of Health Shiraz University of Medical Sciences Shiraz Iran.ORCID 0000-0002-9101-0321
Melika FarshidianfarHealth Policy Research Center, Institute of Health Shiraz University of Medical Sciences Shiraz Iran.
Farshad HadianfardShiraz School for Medicine Shiraz University of Medical Sciences Shiraz Iran.
Fatemeh AlamdariShiraz School for Medicine Shiraz University of Medical Sciences Shiraz Iran.
Omid KeshavarzianShiraz School for Medicine Shiraz University of Medical Sciences Shiraz Iran.
Majid NimrouziResearch Center for Traditional Medicine and History of Medicine Shiraz University of Medical Sciences Shiraz Iran.
Seyed Taghi HeydariHealth Policy Research Center, Institute of Health Shiraz University of Medical Sciences Shiraz Iran.ORCID 0000-0001-7711-1137
Maryam AkbariHealth Policy Research Center, Institute of Health Shiraz University of Medical Sciences Shiraz Iran.ORCID 0000-0002-9211-6371

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Aims: In this study, we investigated the effects of Methods: PubMed, Embase, Web of Science, Scopus, and Cochrane Library databases were searched to identify trials that assessed the effects of Results: Eight articles were included in this meta-analysis. Conclusions: The current meta-analysis underscores the effects of Z. multiflora in improving the clinical manifestations of patients with pulmonary disease, as well as its anti-inflammatory, immunomodulatory, and antioxidant effects. However, more trials with larger samples and longer observation durations are needed to strengthen the evidence for widespread supplementation of

Indexed as

anti‐inflammatory agentsantioxidantslung diseasesrespiratory function testsZataria multiflora Boiss

Identifiers

PMID40330764
PMCPMC12052514

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.